Literature DB >> 33227497

Human cathepsin X/Z is a biologically active homodimer.

Iztok Dolenc1, Ivica Štefe2, Dušan Turk3, Ajda Taler-Verčič2, Boris Turk2, Vito Turk4, Veronika Stoka5.   

Abstract

Human cathepsin X belongs to the cathepsin family of 11 lysosomal cysteine proteases. We expressed recombinant procathepsin X in Pichia pastoris in vitro and cleaved it into its active mature form using aspartic cathepsin E. We found, using size exclusion chromatography, X-ray crystallography, and small-angle X-ray scattering, that cathepsin X is a biologically active homodimer with a molecular weight of ~53 kDa. The novel finding that cathepsin X is a dimeric protein opens new horizons in the understanding of its function and the underlying pathophysiological mechanisms of various diseases including neurodegenerative disorders in humans.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cathepsin X; Cathepsin Z; Homodimer; Procathepsin X; Protease; Small-angle X-ray scattering

Year:  2020        PMID: 33227497     DOI: 10.1016/j.bbapap.2020.140567

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  3 in total

1.  Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy.

Authors:  Ana Mitrović; Janja Završnik; Georgy Mikhaylov; Damijan Knez; Urša Pečar Fonović; Petra Matjan Štefin; Miha Butinar; Stanislav Gobec; Boris Turk; Janko Kos
Journal:  Cell Mol Life Sci       Date:  2022-01-06       Impact factor: 9.261

2.  Evolutionary Analysis of Dipeptidyl Peptidase I.

Authors:  Nina Varda; Marko Novinec
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

3.  Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors.

Authors:  Bernarda Majc; Anamarija Habič; Metka Novak; Ana Rotter; Andrej Porčnik; Jernej Mlakar; Vera Župunski; Urša Pečar Fonović; Damijan Knez; Nace Zidar; Stanislav Gobec; Janko Kos; Tamara Lah Turnšek; Anja Pišlar; Barbara Breznik
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.